Darrell Morgan

Darrell Morgan has extensive experience in the pharmaceutical and veterinary medicine industry. Darrell is currently the Chief Operating Officer at Pacific Edge Ltd since 2022. Prior to this, they held several positions at Argenta, starting as the Head of Contract R&D from 2013 to 2017. Darrell then became the Global Head of Pharmaceutical Sciences, responsible for R&D activities in New Zealand, the USA, and Scotland. Later, they served as the VP of Customer Relationships and then VP of Business Development RD&I Portfolio, where they developed and executed the RD&I business strategy and managed client relationships. Darrell also worked at UCB, where they directed medical device development and led the development of sterile drug products. At Oxford GlycoSciences, they managed the development of an orphan drug for Gaucher's Disease. Darrell Morgan's expertise lies in product development, business strategy, customer relationships, and pharmaceutical sciences.

Darrell Morgan pursued their education at the University of Brighton from 1997 to 1999. During this period, they completed a post-graduate degree in Industrial Pharmaceutical Science.